NeoGenomics, Inc. Line of Credit Facility, Remaining Borrowing Capacity
NeoGenomics, Inc. (NEO) had Line of Credit Facility, Remaining Borrowing Capacity of $8.00 million as of 2014-06-30, per its 10-Q filed 2014-07-29.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity · last filed 2014-07-29
- 2014-06-30: Line of Credit Facility, Remaining Borrowing Capacity $8.00M.
- 2014-03-31: Line of Credit Facility, Remaining Borrowing Capacity $4.20M.
- 2013-12-31: Line of Credit Facility, Remaining Borrowing Capacity $5.70M.
- 2013-09-30: Line of Credit Facility, Remaining Borrowing Capacity $7.30M.
| Period end | Line of Credit Facility, Remaining Borrowing Capacity |
|---|---|
| 2014-06-30 | $8.00M 10-Q · filed 2014-07-29 |
| 2014-03-31 | $4.20M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $5.70M 10-K · filed 2014-02-24 |
| 2013-09-30 | $7.30M 10-Q · filed 2013-10-30 |
| 2013-06-30 | $6.80M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $5.80M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $500.00K 10-K · filed 2013-02-21 |
| 2012-09-30 | $300.00K 10-Q · filed 2012-11-05 |
| 2012-06-30 | $1.60M 10-Q/A · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |